Nabeel
Nabeel Al-Kady, Alexandria EG
Patent application number | Description | Published |
---|---|---|
20110213629 | CAR SHARING - Among other things, through an online site, owners of assets and borrowers of assets can arrange sharing transactions with respect to the assets. Online confirmation is provided to the owners and the borrowers that the arranged sharing transactions have been covered by insurance. Completion of the arranged sharing transactions is managed using information from electronic devices associated with the assets. | 09-01-2011 |
20120330696 | Car Sharing - Among other things, through an online site, owners of assets and borrowers of assets can arrange sharing transactions with respect to the assets. Online confirmation is provided to the owners and the borrowers that the arranged sharing transactions have been covered by insurance. Completion of the arranged sharing transactions is managed using information from electronic devices associated with the assets. | 12-27-2012 |
Nabeel Bardeesy, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20120122991 | METHOD FOR TREATING CANCER BY INCREASING AMP-ACTIVATED KINASE ACTIVITY - The invention relates to modulation of LKB1 or AMP kinase protein activity for treating disorders including diabetes and cancer. The invention also relates to screening for agents that modulate the activity of LKB1 or AMP kinase protein, which are useful in the treatment of diabetes and cancer, as well as preparing compounds for treatment of diabetes and cancer. | 05-17-2012 |
Nabeel Bardeesy, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20110119776 | METHODS OF DIAGNOSING AND PROGNOSING LUNG CANCER - The present invention provides methods of detecting cancer using biomarkers. | 05-19-2011 |
Nabeel Bardeesy, Framingham, MA US
Patent application number | Description | Published |
---|---|---|
20110182814 | PLECTIN-1 TARGETED AGENTS FOR DETECTION AND TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA - Described herein are compositions and methods for cancer cell biomarkers, such as pancreatic ductal adenocarcinoma (PDAC) cell biomarkers, and binding molecules for diagnosis and treatment of cancer, e.g., PDAC. Methods of identifying “accessible” proteomes are disclosed for identifying cancer biomarkers, such as plectin-1, a PDAC biomarker. Additionally, imaging compositions are provided comprising magnetofluorescent nanoparticles conjugated to peptide ligands for identifying PDACs. | 07-28-2011 |
20150151010 | Plectin-1 Targeted Agents for Detection and Treatment of Pancreatic Ductal Adenocarcinoma - Described herein are compositions and methods for cancer cell biomarkers, such as pancreatic ductal adenocarcinoma (PDAC) cell biomarkers, and binding molecules for diagnosis and treatment of cancer, e.g., PDAC. Methods of identifying “accessible” proteomes are disclosed for identifying cancer biomarkers, such as plectin-1, a PDAC biomarker. Additionally, imaging compositions are provided comprising magnetofluorescent nanoparticles conjugated to peptide ligands for identifying PDACs. | 06-04-2015 |
Nabeel El-Bardeesy, Framingham, MA US
Patent application number | Description | Published |
---|---|---|
20100092476 | PANCREATIC CANCER BIOMARKERS - The present invention provides a method of diagnosing, prognosing or screening for pancreatic cancer in a subject. The method may be carried out on a sample such as a blood or tissue sample collected from the subject. The is carried out by (a) detecting one or more markers in a biological sample of said subject, said markers selected from the markers set forth in Table 1 (e.g. one or more markers selected from the group set forth in Table 2, and/or the group consisting of ALCAM, TIMP-1, ICAM1, LCN2, REG1A, REG3, IGFBP4, TNFRSF1A and WFDC2); and (b) determining an altered level of said marker(s), said altered level indicating said subject may be afflicted with or at risk of developing pancreatic cancer. Kits useful for carrying out the methods are also described. | 04-15-2010 |
Nabeel El-Bardeesy, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20080242742 | Animal models of pancreatic adenocarcinoma and uses therefor - The present invention is based, at least in part, on the generation of an animal model of pancreatic adenocarcinoma which recapitulates the genetic and histological features of human pancreatic adenocarcinoma, including the initiation, maintenance, and progression of the disease. Accordingly, the present invention provides animal models of cancer, e.g., pancreatic adenocarcinoma, wherein an activating mutation of Kras has been introduced, and any one or more known or unknown tumor suppressor genes or loci, e.g., Ink4a/Arf, Ink4a, Arf, p53, Smad4/Dpc, Lkb1, Brca2, or Mlh1, have been misexpressed, e.g., have been misexpressed leading to decreased expression or non-expression. The animal models of the invention may be used, for example, to identify biomarkers of pancreatic cancer, to identify agents for the treatment or prevention of pancreatic cancer, and to evaluate the effectiveness of potential therapeutic agents. | 10-02-2008 |
Nabeel Koshak, Makkah SA
Patent application number | Description | Published |
---|---|---|
20160005054 | DECISION SUPPORT SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT - A system, method, and computer program product are described that implement an analysis system that provides a quantitative basis for redirecting research projects, marketing efforts, and innovation initiatives. A computer implemented decision tool and method is described with a graphics user interface that provides a visual dashboard of fused research/innovation/market activities for observing imbalance in professional activities. The system provides graphical analysis to recommend management oversight adjustments of funding initiatives to provide a greatest return on investment. | 01-07-2016 |
Nabeel Shamim, Morris Plains, NJ US
Patent application number | Description | Published |
---|---|---|
20110010200 | Patient and Physician Communication Tool - A method of performing communication between a healthcare provider and a patient by accessing a communication server includes a healthcare provider module, a patient module, and a database. The patient registers and accesses the patient module. The healthcare provider registers and accesses the healthcare provider module. The database includes information associated with the patient and the healthcare provider. The method includes processing an agreement of the patient to access a message from the database, providing a list of authorized individuals being granted permission to access the a messages from the database, communicating an identification code to the patient and to the authorized individuals, and displaying a mailbox interface associated with the patient module to the patient on the identification code being entered. The message is accessed on-demand from the patient module. The message is accessed by any of the patient and the authorized individuals. | 01-13-2011 |